Results 141 to 150 of about 25,328 (173)

PACIFIC-5 Trial: Refining Patient Selection for Consolidation Durvalumab in Unresectable Stage III NSCLC. [PDF]

Thorac Cancer
Zhou S, Ke Q.
europepmc   +1 more source

The evolution of non-surgical management in stage III non-small cell lung cancer. [PDF]

BJC Rep
Patel MS, Hammond A, Dee EC, Iyengar P.
europepmc   +1 more source

Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report. [PDF]

Oncol Res
Abdelrahim W, Al-Najjar E, El Beheary S, Esmail A.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Durvalumab

Reactions Weekly, 2022
  +10 more sources

Durvalumab

Reactions Weekly, 2021
  +9 more sources